Skip to main content
Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology.
Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagement.
Past, present and future of Focused Ultrasound as an adjunct or complement to DIPG/DMG therapy: A consensus of the 2021 FUSF DIPG meeting.
Retrospective dataset and survey analyses identify gaps in data collection for craniopharyngioma and priorities of patients and families affected by the disease.
Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era.
Interdisciplinary care of children with diffuse midline glioma.
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.
The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53.
Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction.